Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 4, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, April 3, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Francois Brisebois Upgraded (ALDX) to Buy and Held Target at $10 on, Apr 3rd, 2024
Francois Brisebois of Oppenheimer, Upgraded "Aldeyra Therapeutics, Inc." (ALDX) to Buy and Held Target at $10 on, Apr 3rd, 2024.
Francois has made no other calls on ALDX in the last 4 months.
There is 1 other peer that has a rating on ALDX. Out of the 1 peers that are also analyzing ALDX, 0 agree with Francois's Rating of Hold.
This is the rating of the analyst that currently disagrees with Francois
- Matthew Caufield of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $10 on, Tuesday, April 2nd, 2024
